New Federal Lawsuit Says Contaminated Valsartan Caused La. Man’s Death



DOCUMENTS
  • Complaint


LAFAYETTE, La. — The widow of a man who died from kidney cancer after ingesting allegedly contaminated valsartan has filed a wrongful death action against the drug’s makers in Louisiana federal court, accusing them of knowing the drug was adulterated, yet touting its safety to doctors and consumers.

In the Nov. 15 complaint filed in the U.S. District Court for the Western District of Louisiana, the plaintiff further alleges defendants Zhejiang Huahai Pharmaceutical Co., Huahai US Inc., Solco Healthcare U.S. and Prinston Pharmaceutical Inc. ignored warning signs of contamination at the Chinese manufacturing plant where the drug is made.

The …

FIRM NAMES
  • Law Offices of Kenneth W. DeJean





UPCOMING CONFERENCES




HarrisMartin’s Webinar Series: Surgical Stapler Litigation

January 14, 2021 - Haddonfield, NJ
HarrisMartin Webinar Series

MORE DETAILS



HarrisMartin's Webinar Series: Midwest Asbestos Litigation

December 02, 2020 - Haddonfield, NJ
HarrisMartin Webinar Series

MORE DETAILS